Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
TORL Biotherapeutics LLC
What AI says about TORL Biotherapeutics LLC
TORL BioTherapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based therapies for cancer treatment. Their innovative pipeline includes multiple clinical programs targeting specific molecular signatures in various cancers.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
Products & Services
Antibody-based Therapies
A portfolio of clinical-stage antibody-drug conjugates (ADCs) aimed at treating various solid tumors and blood cancers.
Common Questions
What is TORL BioTherapeutics focused on?
TORL BioTherapeutics is dedicated to developing antibody-based therapies to improve the lives of cancer patients.
What is the lead program of TORL BioTherapeutics?
The lead program is TORL-1-23, a clinical-stage ADC targeting CLDN6+ solid tumors.
What types of cancers do TORL's therapies target?
TORL's therapies target various cancers, including ovarian, non-small cell lung, endometrial, and testicular malignancies.